| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,842 |
6,070 |
$15K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
842 |
822 |
$10K |
| 95117 |
|
5,857 |
2,304 |
$3K |
| 95144 |
|
416 |
173 |
$3K |
| 94010 |
|
2,675 |
2,487 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
484 |
481 |
$2K |
| 94200 |
|
2,494 |
1,230 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
578 |
558 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
394 |
343 |
$1K |
| 94060 |
|
238 |
237 |
$771.14 |
| 99243 |
|
67 |
67 |
$556.52 |
| 95024 |
|
59 |
58 |
$357.21 |
| 94664 |
|
629 |
580 |
$135.25 |
| 95012 |
|
140 |
135 |
$121.90 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,652 |
616 |
$91.26 |
| 99072 |
|
25 |
16 |
$23.80 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
126 |
126 |
$10.91 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
140 |
140 |
$1.04 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$0.00 |